Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

December 25, 2025

Study Completion Date

October 1, 2026

Conditions
Intracerebral Hemorrhage
Interventions
DRUG

MW189

MW189 (0.25 mg/kg) is administered within 24 hours of symptom onset and every 12 hours for up to 5 days (10 total doses) or until discharge (if earlier than 5 days)

OTHER

Saline

Administration of saline within 24 hours of symptom onset and every 12 hours for up to 5 days (10 total doses) or until discharge (if earlier than 5 days)

Trial Locations (11)

11220

RECRUITING

New York University Grossman School of Medicine, Brooklyn

21287

RECRUITING

Johns Hopkins Hospital, Baltimore

34994

RECRUITING

Cleveland Clinic Florida, Stuart

35294

RECRUITING

University of Alabama Birmingham, Birmingham

40536

RECRUITING

University of Kentucky, Lexington

45219

RECRUITING

University of Cincinnati, Cincinnati

77030

RECRUITING

University of Texas Houston, Houston

78229

RECRUITING

University of Texas San Antonio, San Antonio

87131

NOT_YET_RECRUITING

University of New Mexico, Albuquerque

94304

NOT_YET_RECRUITING

Stanford University, Palo Alto

06511

RECRUITING

Yale New Haven Hospital, New Haven

All Listed Sponsors
collaborator

University of Kentucky

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

Johns Hopkins University

OTHER